
Use of Carcinoembryonic Antigen Radioimmunodetection and Computed Tomography for Predicting the Resectability of Recurrent Colorectal Cancer
Author(s) -
Kevin S. Hughes,
Carl M. Pinsky,
Nicholas J. Petrelli,
Frederick L. Moffat,
Yehuda Z. Patt,
Luz Hammershaimb,
David M. Goldenberg
Publication year - 1997
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/00000658-199711000-00007
Subject(s) - medicine , colorectal cancer , concordance , carcinoembryonic antigen , radiology , metastasis , cancer , oncology
The objective was to determine the role of arcitumomab (CEA-Scan; Immunomedics, Morris Plains, NJ), an anticarcinoembryonic antigen (CEA) Fab' labeled with technetium-99m, in the presurgical evaluation of patients with recurrent or metastatic colorectal carcinoma.